NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
4.310
-0.300 (-6.51%)
Apr 28, 2026, 4:00 PM EDT - Market closed
NTHI Employees
NeOnc Technologies Holdings had 5 employees as of December 31, 2025. The number of employees decreased by 3 or -37.50% compared to the previous year.
Employees
5
Change
-3
Growth
-37.50%
Revenue / Employee
$7,998
Profits / Employee
-$12,429,242
Market Cap
107.37M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 174 |
| Cibus | 118 |
| Immunic | 92 |
| Verrica Pharmaceuticals | 76 |
| Pyxis Oncology | 56 |
| Vivani Medical | 42 |
| Aardvark Therapeutics | 40 |
| Cardiff Oncology | 31 |
NTHI News
- 27 days ago - NeOnc Provides Business Update and Reports Q4 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - NeOnc Technologies Appoints David Choi as Chief Accounting Officer - GlobeNewsWire
- 6 weeks ago - Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) - Newsfile Corp
- 7 weeks ago - NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET - GlobeNewsWire
- 2 months ago - NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity - GlobeNewsWire
- 3 months ago - NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management - GlobeNewsWire
- 3 months ago - Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) - Newsfile Corp
- 4 months ago - NeOnc Technologies Reports Updated Clinical Results - GlobeNewsWire